Serum from Patients with Hypertension Promotes Endothelial Dysfunction
Total Page:16
File Type:pdf, Size:1020Kb
MOLECULAR MEDICINE REPORTS 23: 319, 2021 Serum from patients with hypertension promotes endothelial dysfunction to induce trophoblast invasion through the miR‑27b‑3p/ATPase plasma membrane Ca2+ transporting 1 axis LIBO ZHU and ZHUQING LIU Department of Obstetrics, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China Received November 14, 2019; Accepted August 8, 2020 DOI: 10.3892/mmr.2021.11958 Abstract. Pregnancy‑induced hypertension is often miR‑27b‑3p mimics reduced the expression level of ATP2B1, accompanied by preeclampsia. The present study investigated and miR‑27b‑3p inhibitor reversed the effect of hypertensive whether microRNA (miR)‑27b‑3p affected the occurrence serum on ATP2B1 expression. Furthermore, patients with of preeclampsia by regulating the function of endothelial hypertension showed increased endothelial dysfunction, cells. Expressions levels of miR‑27b‑3p and ATPase plasma reduced trophoblastic invasion and the expressions of VEGF, membrane Ca2+ transporting 1 (ATP2B1) were determined MMP‑2 and MMP‑9, and miR‑27b‑3p mimics and silencing using reverse‑transcription quantitative PCR. miR‑27b‑3p of ATP2B1 produced similar results to HUVECs. The targeting ATP2B1 was predicted using bioinformatics and miR‑27b‑3p inhibitor reversed the effect of hypertensive further confirmed by dual‑luciferase reporter assays. Cell serum, and silencing of ATP2B1 inhibited the improvement Counting Kit‑8, Transwell and Matrigel tube formation of miR‑27b‑3p inhibitor to HUVECs and HTR‑8/SVneo cells assays were performed to detect the effects of miR‑27b‑3p on in proliferation, migration and tube formation. The current proliferation, migration and tube formation of human umbilical findings suggested that miR‑27b‑3p promoted proliferation, vein endothelial cells (HUVECs), respectively. Moreover, migration and tube formation of HUVECs and enhanced HTR8/SVneos cells were co‑cultured with HUVECs to invasion of trophoblast cells, via regulation of ATP2B1. Thus, detect the invasion of trophoblast cells, and the expression miR‑27b‑3p could be considered as a molecular risk factor in levels of vascular endothelial growth factor (VEGF), matrix the pathogenesis and development of preeclampsia. metalloproteinase (MMP)‑2 and MMP‑9 of HUVECs and HTR8/SVneos were detected by western blotting. Expression Introduction levels of miR‑27b‑3p were upregulated in the serum of patients with hypertension and preeclampsia, which could target and Preeclampsia is a pregnancy‑specific hypertensive disorder regulate the expression of ATP2B1. The expression levels that may lead to the death of newborns and pregnant of miR‑27b‑3p were increased and those of ATP2B1 were women (1). Patients with preeclampsia are likely to have reduced in HUVECs from hypertensive serums. Moreover, placental dysplasia, which seriously affects the health of pregnant women and fetuses. Pregnant women with chronic hypertension have a significantly higher risk of developing preeclampsia compared with healthy pregnant women. For those with a family history of preeclampsia, the incidence Correspondence to: Dr Zhuqing Liu, Department of Obstetrics, of chronic hypertension is further greatly increased (2). In Affiliated Hangzhou First People's Hospital, Zhejiang University addition, the risk of patients with preeclampsia having chronic School of Medicine, 261 Huansha Road, Shangcheng, Hangzhou, hypertension is estimated to be higher in the future compared Zhejiang 310006, P.R. China with now (3,4). Researchers confirmed that the ATP2B1 gene E‑mail: [email protected] is a gene susceptible to chronic hypertension among different Abbreviations: ATP2B1, ATPase plasma membrane Ca2+ races (5‑7). transporting 1; HUVECs, human umbilical vein endothelial The ATP2B1 gene, located at 12q21.3, encodes the ATPase 2+ cells; FBS, fetal bovine serum; RT‑qPCR, reverse‑transcription plasma membrane Ca transporting 1 (ATP2B1) protein, quantitative PCR; TFP, trifluoperazine which belongs to the P‑type ion transport ATPase family of proteins and is widely expressed in mammals (8). In 2009, Key words: microRNA‑27b‑3p, ATPase plasma membrane Ca2+ through use of a genome‑wide association study, Levy et al (9) transporting 1, HUVECs, hypertension, preeclampsia conducted a large cohort study on two European populations, and found a single nucleotide polymorphism locus associated with chronic hypertension; the SNPrs2681472 locus located 2 ZHU and LIU: THE ROLE OF miR‑27b‑3p IN PREECLAMPSIA in the ATP2B1 gene. SNPrs2681472 polymorphism of i) Hypertension after 20 weeks of pregnancy and ii) positive ATP2B1 gene has been previously reported to be associated proteinuria. Systolic blood pressure (>140 mmhg) and/or with early‑onset preeclampsia among Chinese pregnant diastolic blood pressure (>90 mmhg) served as diagnostic women (10). The SNPrs2681472 polymorphism of ATP2B1 criteria for hypertension, with proteinuria ≥0.3 g/24 h. Patients gene may participate in the regulation of hypertension and with a history of diabetes, chronic kidney disease and/or heart preeclampsia by affecting ATP2B1 gene expression levels (5). disease were excluded. The venous blood of pregnant women In recent years, the effects of microRNAs (miRNAs/miRs) was collected (3 ml) at birth and centrifuged at 12,000 x g for on hypertension and preeclampsia have been widely studied. 8 min at 4˚C. The serums were stored at ‑80˚C. miRNAs are non‑coding RNAs 21‑25 nucleotides in length, and are involved in ~30% of the regulation of gene expressions Cell culture and treatment. HUVECs and HTR‑8/SVneo cells in the human genomes (11). A previous study by Wang et al (12) were purchased from The Cell Bank of Type Culture Collection found that compared with normal pregnant women, the of the Chinese Academy of Sciences. The cells were grown in expression levels of nine miRNAs, namely, miR‑223, ‑195, RPMI‑1640 media containing 10% fetal bovine serum (FBS, ‑17, ‑18a, ‑218, ‑19b1, ‑379, ‑92a1 and miR‑411, are reduced in Gibco; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin placenta tissues of patients with severe preeclampsia compared and 100 ng/ml streptomycin (Sigma‑Aldrich; Merck KGaA) with controls. Moreover, the expression of another seven in a humid incubator at 37˚C with CO2. When the density miRNAs (miR‑30a‑3p, ‑210, ‑524, ‑518b, ‑18a, ‑17‑3 and ‑411) of cells (1x106 cells/ml) reached 70‑80%, the cells either are also reduced, and miR‑151 and miR‑193b expression remained untransfected or were transfected with miR‑27b‑3p levels are increased in the tissues derived from patients with inhibitor control (cat. no. 4464076, Thermo Fisher Scientific, preeclampsia (13). Previous studies showed that miR‑125b‑5p, Inc.,), miR‑27b‑3p inhibitor (cat. no. 4464084, Thermo Fisher ‑100‑5p and ‑199a‑5p have a low level of expression in Scientific, Inc.,) or miR‑27b‑3p mimics (cat. no. 4464066, the peripheral blood of patients with pregnancy‑induced Thermo Fisher Scientific, Inc.,) using Lipofectamine® hypertension and preeclampsia (14). Compared with normal RNAiMAX (Invitrogen; Thermo Fisher Scientific, Inc.). After pregnant women, the levels of total miRNAs and hsa‑miR‑210 recovery in fresh medium for 24 h, the cells transfected with in peripheral blood of pregnant women with hypertensive either the miR‑27b‑3p inhibitor control or miR‑27b‑3p inhib‑ are significantly increased. hsa‑miR‑210 has been seen itor were cultured in the medium added with 10% serum from as a suitable biomarker for indicating pregnancy‑induced patients with hypertension for 24 h as Serum + control (C) hypertension (15). Moreover, miR‑210 is involved in the cells and Serum + inhibitor (I) cells. The untransfected cells pathogenesis of preeclampsia (16). Recently, it has been or those transfected with miR‑27b‑3p mimics, mimics control found that miR‑27b‑3p participates in various pathological (MC) and inhibitor control (IC) were cultured in fresh medium processes, including in tumor angiogenesis, lipid metabolism, for 24 h as C cells, mimic (M) cells, MC and IC cells. inflammatory response and the oxidative stress response (17). The present study was designed to explore the relationship Reveres‑transcription‑quantitative PCR (RT‑qPCR) assay. between hypertension and preeclampsia, and the role of Total miRNAs were separated from tissues and cells using a miR‑27b‑3p. miR‑27b‑3p was found to be upregulated in miRNeasy Mini kit (cat. no. 217004; Qiagen GmbH) following patients with hypertension and patients with preeclampsia. The the manufacturer's instructions, and 1 µg of miRNAs was used effects of miR‑27b‑3p on HUVECs stimulated by the serum of to obtain cDNAs with a miScript II reverse transcription kit patients with hypertension were investigated. Moreover, the (cat. no. 218160; Qiagen GmbH) at 37˚C for 15 min and 98˚C effects of miR‑27b‑3p on HTR‑8/SVneo cells co‑cultured with for 5 min. In addition, total cellular RNA was isolated using HUVECs cells were explored, following stimulation by the TRIzol® reagent (Invitrogen; Thermo Fisher Scientific, Inc.), serum of patients with hypertension. These results confirmed and the SMART MMLV Reverse Transcriptase (cat. no. 639523; that miR‑27b‑3p might be a diagnostic marker for hypertension Takara Bio, Inc.) was used to reverse‑transcribe mRNAs into and preeclampsia. cDNAs at 37˚C for 15 min and 98˚C for 5 min. Then, the levels of miRNAs were detected using a miScript SYBR‑Green PCR Materials and methods kit (cat. no. 218075; Qiagen GmbH) according to the manufac‑ turer's instructions (18), and the mRNA levels were measured Patients. Normal pregnant women (n=21; age 33.5±4; body using SYBR Premix Ex Taq kit (cat. no. RR820A; Takara mass index 22.3±3 kg/m2; vaginal delivery), women with Bio, Inv.) in an ABI7300 Thermocycler (Applied Biosystems; preeclampsia (n=21; age 34.1±5; body mass index 24.6±4 kg/m2; Thermo Fisher Scientific, Inc.). U6 served as an endogenous vaginal delivery), female patients with hypertension (n=13; control of miRNA, and GAPDH was used to normalize the 51.5±4) and female healthy volunteers (n=13; 52.5±4), who mRNAs.